STAAR Surgical Co last reported quarterly results on Nov 4, 2026, for Q3 FY2026 (the quarter ended Oct 2, 2026): revenue of $83.4 million (-12.0% year over year) and diluted EPS of $0.11. It usually reports 33–60 days after a quarter ends. Based on that pattern, the next release is estimated for around Mar 2, 2027.
Results for Q4 FY2026, the quarter ending around Jan 1, 2027. Expected on a Tuesday. Based on last year's release for the same quarter on Mar 3, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 33–60 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 4, 2026
33 days after quarter end
|
Q3 FY2026
ended Oct 2, 2026
|
83
-12.0%
|
6
-37.2%
|
0.11
-38.9%
|
|
Aug 12, 2026
40 days after quarter end
|
Q2 FY2026
ended Jul 3, 2026
|
94
+111.0%
|
8
+147.9%
|
0.16
+147.1%
|
|
May 13, 2026
40 days after quarter end
|
Q1 FY2026
ended Apr 3, 2026
|
94
+119.6%
|
5
+109.6%
|
0.10
+109.1%
|
|
Mar 3, 2026
60 days after quarter end
|
Q4 FY2025
ended Jan 2, 2026
|
58
+18.1%
|
-18
+46.5%
|
-0.37
+48.8%
|
|
Oct 20, 2025
24 days after quarter end
|
Q3 FY2025
ended Sep 26, 2025
|
95
+6.9%
|
9
-11.0%
|
0.18
-10.0%
|
|
Aug 6, 2025
40 days after quarter end
|
Q2 FY2025
ended Jun 27, 2025
|
44
-55.2%
|
-17
-327.8%
|
-0.34
-326.7%
|
|
May 7, 2025
40 days after quarter end
|
Q1 FY2025
ended Mar 28, 2025
|
43
-44.9%
|
-54
-1523.6%
|
-1.10
-1471.4%
|
|
Feb 11, 2025
46 days after quarter end
|
Q4 FY2024
ended Dec 27, 2024
|
49
-35.8%
|
-34
-541.3%
|
-0.72
-555.8%
|
Company profile
- Industry
- Ophthalmic Goods (SIC 3851)
- Listed as
- STAA (Nasdaq)
- Fiscal year ends
- January 2
- Incorporated in
- DE
- Headquarters
- Monrovia, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 718937
- Former names
- STAAR SURGICAL COMPANY (until Aug 17, 2004)
Other Ophthalmic Goods companies
- Alcon Inc ALC
- Cooper Companies, Inc. COO
- Bausch & Lomb Corp BLCO
- Warby Parker Inc. WRBY
- National Vision Holdings, Inc. EYE
- RxSight, Inc. RXST
- Innovative Eyewear Inc LUCY
Source: SEC EDGAR filings. This is company-reported data, not investment advice.